For over a decade, Entext has provided global institutional investors with distinctive asset allocation and thematic research. We seek actionable insights that challenge the market consensus and have a demonstrable track record in identifying key secular trends as well as tactical cross-asset inflection points, amid the confirmation bias that typifies much sell-side analysis.
For instance, in 2020, we warned clients from late January that the consensus was underestimating China's lockdown impact/global pandemic risks and shorted EM and US HY accordingly. We then highlighted from mid-March the prospect of a liquidity fuelled rally to new highs in equity and credit indices switching to long tactical positions in cyclical, high beta markets like Korea and Japan.
Thematic coverage of key structural trends is expressed via baskets of large cap global stocks. In 2020, these again outperformed, returning for example from 145% for alternative energy, to 60% for ecommerce automation 52% for social gaming/e-sports and 41% for autonomous vehicles.
Please contact us for further details or visit ENTX <Go> on Bloomberg for trial entitlement.
Access is also available by request via other leading financial data platforms including Refinitiv and FactSet
Proven Alpha Generation
Our analysis is designed to be highly actionable via specific and typically non-consensus market insights.
A sample track record of contrarian, uncorrelated ideas over recent years is available.
Cohesive Multi-Asset Analysis
We seek to cut through market noise to identify critical trends and inflection points in relative performance - and make that process an incisive and stimulating read.
Our Weekly Insight note covers key structural themes and tactical opportunities. Clients regard the analysis as unusually wide ranging, asset agnostic and coherent.
Macro Impact of Technology
Understanding the macro and portfolio construction implications of key technology trends such as the digital consumption 'metaverse' is a key differentiating feature of our analysis.
Please contact us for details of a trial subscription and client roadshows.